Hip Fracture Impact on Vascular Events In Noncardiac Surgery patIents: a cOhort evaluatioN (Hip VISION): Pilot Study

October 5, 2015 updated by: P.J. Devereaux, Population Health Research Institute
Hip VISION (Pilot Study) is a Prospective Observational Cohort Study to evaluate the incidence of overall and cause-specific mortality among consecutive patients aged ≥ 18 years presenting with hip fracture to the Juravinski Hospital of the Hamilton Health Sciences. This pilot study will assess the feasibility of a larger prospective international cohort study. After eligibility has been confirmed and informed consent has been obtained, participants will be registered in the study. Troponin level, complete blood counts and serum creatinine level will be collected at day 1 through day 10 post admission. CAM instrument will be employed at admission and once daily post admission day 1 through day 10. FIM Instrument will be administered within 72 hours of admission to establish pre-fracture functional independence and disability. Patients will be contacted by research personnel by telephone 30 days after study registration.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Hamilton, Ontario, Canada, L8V 5C2
        • Juravinski Hospital and Cancer Centre (HHS)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients with hip fracture

Description

Inclusion Criteria:

  1. Patients aged ≥ 18 years with hip fractures (i.e. fractures involving the subcapital, femoral neck, or intertrochanteric regions), treated either operatively or non-operatively
  2. Mechanism of injury consistent with either:

    1. A fall from a standing height or;
    2. Another mechanism of injury which, in the clinical judgment of an orthopedic surgeon, would impart the same or less traumatic energy as a fall from a standing height

Exclusion Criteria:

  1. Patients with fractures isolated to the proximal femoral shaft, with no involvement of the intertrochanteric, femoral neck, or subcapital region
  2. Patients with hip fractures resulting from high energy mechanisms, such as motor vehicle accidents or falls from a substantial height
  3. Patient who refuse 30-day or 6-month follow up
  4. Patients who refuse to consent either by themselves or through a substitute decision-maker (for patients unable to consent, we will use a deferred consent process, as described below).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients with a hip fracture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total and cause specific mortality in hip fracture patients at 30 days
Time Frame: 30 days
30 days
Major complications within 30 days.
Time Frame: 30 days
Composite of vascular mortality, nonfatal MI, nonfatal stroke, nonfatal PE, sepsis, and life-threatening bleeding.
30 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Length of hospital stay
Time Frame: 30 days
30 days
Nonfatal myocardial infarction
Time Frame: 30 days
30 days
Nonfatal myocardial injury after noncardiac surgery
Time Frame: 30 days
30 days
Nonfatal pulmonary embolism
Time Frame: 30 days
30 days
Nonfatal infection
Time Frame: 30 days
30 days
Nonfatal bleeding
Time Frame: 30 days
30 days
Nonfatal stroke
Time Frame: 30 days
30 days
New congestive heart failure
Time Frame: 30 days
30 days
New atrial fibrillation
Time Frame: 30 days
30 days
Nonfatal cardiac arrest
Time Frame: 30 days
30 days
Deep vein thrombosis
Time Frame: 30 days
30 days
New acute renal failure requiring dialysis
Time Frame: 30 days
30 days
Cardiac catheterization
Time Frame: 30 days
30 days
PCI
Time Frame: 30 days
30 days
CABG
Time Frame: 30 days
30 days
CAM days 1-7 post-op
Time Frame: 1-7 days post-op
1-7 days post-op
Implant failure or periprosthetic fracture
Time Frame: 30 days
30 days
Re-operation
Time Frame: 30 days
30 days
New nursing home residence
Time Frame: 30 days
30 days
First mobilization
Time Frame: 30 days
30 days
FIM (motor function)
Time Frame: 30 days
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: PJ Devereaux, PhD, Population Health Research Institute

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

October 1, 2015

Study Registration Dates

First Submitted

November 7, 2013

First Submitted That Met QC Criteria

November 7, 2013

First Posted (Estimate)

November 14, 2013

Study Record Updates

Last Update Posted (Estimate)

October 6, 2015

Last Update Submitted That Met QC Criteria

October 5, 2015

Last Verified

October 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • HipVISION Pilot - 2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Subscribe